- Details
- Written by Super User
- Category: Info
Organizing committee
Zeina ANTOUN, GSK
Vanessa BESSON-DUBOURG, INSERM TRANSFERT
Alice BOUSSELET, INSERM TRANSFERT
Mireille CARALP, INSERM TRANSFERT
Aurélie DEFAUX, ARIIS
Sylvain DURRLEMAN, Aviesan/ITMO Santé Publique
Marco FIORINI, ARIIS
Véronique FOUINAT, ARIIS
Jean-Marie GAGLIOLO, Aviesan/ITMO Santé Publique
Anne HAZIZA, ARIIS
Industrials members of steering committee
BATAMAN-ONAL Yasemin, Sanofi Pasteur
BEZIZ Dan, Lilly
CHEVALIER Marie-Pierre, Pfizer
DELONCA Jean, Shire
DUBOIS Frédéric, Servier
FAUCONNIER Laurence, Stago
JULLIAN Nathalie, Ipsen
LESAGE Sabrina, Pfizer
LONGIN Juliette, Merck
NACHBAUR Gaëlle, GSK
PETIT-NIVARD Jean-Frédéric, Roche
SALZMAN Valérie, Servier
THEVENON Julien, Janssen France / Johnson & Johnson
THOMAS-DELECOURT Florence, AstraZeneca
TIREL Anny, MSD
- Details
- Written by Super User
- Category: Info
Provisional schedule:
October 3rd, 2018 – Paris
| 9:00 am - 9:10 am |
Opening remarks: why France? - Yves LEVY, Chairman of Aviesan & Marc BONNEVILLE, Chairman of ARIIS |
| 9:10 am - 9:30 am |
21st century epidemiology: challenges and opportunities - Gilles BABINET, France’s Digital Champion for the European Commission |
| 9:30 am - 9:50 am |
The "Constances" cohort: design, applications and foresight - Marie ZINS, Scientific leader of Constances |
| 9:50 am - 10:45 am |
Round table 1 - AI for biomarker discovery: what can we truly expect ? - Stanley DURRLEMAN, Researcher, Inria & ICM Brain and Spine Institute - Xosé FERNANDEZ, Chief Data Officer, Curie Institute - Meriem SEFTA, Partnership and Translational Research Manager, Owkin - Benoit TYL, Director of Cardiovascular Translational Research, Servier - Nicolas VILLAIN, Head of Research in AI for Medical Imaging, Philips |
| 10:45 am - 11:00 am |
Practical case - From Paris to Boston: a "deep patient" in nephrology - Alexandre LOUPY, Nephrologist at the Department of Nephrology and Kidney Transplantation, Necker Hospital |
| 11:00 am - 11:30 am |
Coffee break - Networking |
| 11:30 am - 11:50 am |
An insight by a global industry - Human derived genome scale data sets and advances analytics to accelerate drug discovery - Philippe SANSEAU, Head of Computational Biology and Stats, GSK |
| 11:50 am - 12:45 am |
Round table 2 - Real-world data: a broad foresight on this tomorrows' gold standard - Michèle ARNOE, Head Growth and Innovation, IQVIA - Valérie EDEL, Vice-Director, Health data Institute - Marc FROUIN, Chief Operating Officer, BioSerenity - Ramon HERNANDEZ, Head of Advanced Analytics in R&D, Sanofi - Remy SLAMA, Scientific coordinator of the SEPAGES cohort (to be confirmed) |
| 12:45 am - 12:55 pm |
Overview of the rising French start-ups using AI on cohorts - Rosalie MAURISSE, Head of the health sector, Expertise Direction, BpiFrance |
| 12:55 pm - 1:15 pm |
Concluding remarks and insight from Israel - Ran BALICER, Founding Director, Clalit Research Institute of Israel
|
| 1:15 pm - 2:30 pm |
Lunch & Networking with start-ups [PRIVATE ACCESS - by invitation only] |
| 2:30 pm - 6:00 pm |
B2B meetings [PRIVATE ACCESS - by invitation only] |
- Details
- Written by Super User
- Category: Info
Building upon the success of the Cohort Innovation Days held in Paris in 2014 and 2016, ARIIS (Alliance for Research and Innovation in Health Industries) and Aviesan (French National Alliance for Life Sciences and Health) organize a third Cohort Innovation Day on October 3rd, 2018 in "Station F", Paris.
This new edition will focus on cohorts and artificial intelligence.
This one-day event will be composed of 2 main parts:
- In the morning: debates with cutting-edges experts crossing the fields of artificial intelligence and cohorts
- In the afternoon: B2B meetings between industries and cohort project leaders to develop new private/public partnerships